In this article (1), which was published in the September 2009 issue of Cancer Epidemiology, Biomarkers & Prevention, the FOLH1 SNP rs202676 was referred to incorrectly as FOLH1 “1561T>C.” The correct designation is as follows:

rs202676 occurs in exon 2 of FOLH1/GCPII (referred to as 223T>C or 484T>C), corresponding to amino acid substitution Y75H. The 1561C>T polymorphism (also referred to as 1684C>T) occurs in exon 13 of FOLH1, is identified as rs61886492, and corresponds to amino acid substitution H475Y.

1
Collin
SM
,
Metcalfe
C
,
Zuccolo
L
,
Lewis
SJ
,
Chen
L
,
Cox
A
,
Davis
M
,
Lane
JA
,
Donovan
J
,
Smith
GD
,
Neal
DE
,
Hamdy
FC
,
Gudmundsson
J
,
Sulem
P
,
Rafnar
T
,
Benediktsdottir
KR
,
Eeles
RA
,
Guy
M
,
Kote-Jarai
Z
,
UK Genetic Prostate Cancer Study Group
,
Morrison
J
,
Al Olama
AA
,
Stefansson
K
,
Easton
DF
,
Martin
RM
. 
Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis
.
Cancer Epidemiol Biomarkers Prev
2009
;
18
:
2528
39
.